this work references cited by second hopReferences
- 2016Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks, 1990–2015: a systematic analysis for the Global Burden of Disease Study 20157,699 cited
- 2016Psychedelics1,757 cited
- 2006Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance1,682 cited
- 2003The Pharmacology and Clinical Pharmacology of 3,4-Methylenedioxymethamphetamine (MDMA, “Ecstasy”)1,271 cited
- 2018Psychedelics Promote Structural and Functional Neural Plasticity1,201 cited
- 2015Psilocybin-assisted treatment for alcohol dependence: A proof-of-concept study1,150 cited
- 2014Pilot study of the 5-HT 2A R agonist psilocybin in the treatment of tobacco addiction913 cited
- 2017The Therapeutic Potential of Psychedelic Drugs: Past, Present, and Future700 cited
- 2020Psychedelics and Psychedelic-Assisted Psychotherapy649 cited
- 2018Classic psychedelics: An integrative review of epidemiology, therapeutics, mystical experience, and brain network function506 cited
- 2020A non-hallucinogenic psychedelic analogue with therapeutic potential468 cited
- 1992Plants of the Gods: Their Sacred, Healing and Hallucinogenic Powers466 cited
- 2008The Pharmacology of Lysergic Acid Diethylamide: A Review455 cited
- 1986
Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work